OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway
Hangyu Zhang, Yongfang Wang, Changgang Liu, et al.
Pathology - Research and Practice (2021) Vol. 229, pp. 153746-153746
Closed Access | Times Cited: 33
Hangyu Zhang, Yongfang Wang, Changgang Liu, et al.
Pathology - Research and Practice (2021) Vol. 229, pp. 153746-153746
Closed Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 93
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 93
Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis
Liwen Ren, Jie Yi, Yihui Yang, et al.
Pharmacological Research (2022) Vol. 183, pp. 106376-106376
Closed Access | Times Cited: 58
Liwen Ren, Jie Yi, Yihui Yang, et al.
Pharmacological Research (2022) Vol. 183, pp. 106376-106376
Closed Access | Times Cited: 58
TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity
Shafat Ali, Muneeb U. Rehman, Ali Mohd Yatoo, et al.
European Journal of Pharmacology (2023) Vol. 947, pp. 175678-175678
Closed Access | Times Cited: 32
Shafat Ali, Muneeb U. Rehman, Ali Mohd Yatoo, et al.
European Journal of Pharmacology (2023) Vol. 947, pp. 175678-175678
Closed Access | Times Cited: 32
Programmed cell death in tumor immunity: mechanistic insights and clinical implications
Man Wang, Fei Yu, Yuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 9
Man Wang, Fei Yu, Yuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 9
Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer
Jia Wang, Wen‐Feng Zhang, Cun Liu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1884-1904
Open Access | Times Cited: 9
Jia Wang, Wen‐Feng Zhang, Cun Liu, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1884-1904
Open Access | Times Cited: 9
Apolipoproteins: New players in cancers
Yingcheng He, Jianrui Chen, Yanbing Ma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Yingcheng He, Jianrui Chen, Yanbing Ma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Integrating single-cell RNA-seq and bulk RNA-seq to explore prognostic value and immune landscapes of methionine metabolism-related signature in breast cancer
Yingchun Gao, Ziyu Feng, Hailong Zhao, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Yingchun Gao, Ziyu Feng, Hailong Zhao, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Identifying Novel Aging-Related Biomarkers for Age-related Macular Degeneration with Integrative Bioinformatics Approaches
Lan Zhao
Theoretical and Natural Science (2025) Vol. 90, Iss. 1, pp. 1-23
Closed Access
Lan Zhao
Theoretical and Natural Science (2025) Vol. 90, Iss. 1, pp. 1-23
Closed Access
A simplified MyProstateScore2.0 for high-grade prostate cancer
Tiffany M. Tang, Yuping Zhang, Ana Kenney, et al.
Cancer Biomarkers (2025) Vol. 42, Iss. 1
Closed Access
Tiffany M. Tang, Yuping Zhang, Ana Kenney, et al.
Cancer Biomarkers (2025) Vol. 42, Iss. 1
Closed Access
APOC1 promotes the progression of osteosarcoma by binding to MTCH2
Renjie Li, Huixian He, Xinxin He
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 11
Renjie Li, Huixian He, Xinxin He
Experimental and Therapeutic Medicine (2023) Vol. 25, Iss. 4
Open Access | Times Cited: 11
Huanglian Ganjiang decoction alleviates ulcerative colitis by restoring gut barrier via APOC1-JNK/P38 MAPK signal pathway based on proteomic analysis
Yue-Xian He, Yanyang Li, Ye-Qun Wu, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116994-116994
Closed Access | Times Cited: 11
Yue-Xian He, Yanyang Li, Ye-Qun Wu, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116994-116994
Closed Access | Times Cited: 11
Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway
Chengwen Zhao, Lu Zheng, Yuting Ma, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 3
Chengwen Zhao, Lu Zheng, Yuting Ma, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 3
A risk prediction model mediated by genes of APOD/APOC1/SQLE associates with prognosis in cervical cancer
Ya Zhang, Yuan-Kun Qin, Danqing Li, et al.
BMC Women s Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Ya Zhang, Yuan-Kun Qin, Danqing Li, et al.
BMC Women s Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Decreased APOC1 expression inhibited cancer progression and was associated with better prognosis and immune microenvironment in esophageal cancer.
Qiang Guo, Xiaoli Liu, Ni Jiang, et al.
PubMed (2022) Vol. 12, Iss. 11, pp. 4904-4929
Closed Access | Times Cited: 13
Qiang Guo, Xiaoli Liu, Ni Jiang, et al.
PubMed (2022) Vol. 12, Iss. 11, pp. 4904-4929
Closed Access | Times Cited: 13
ZNF460 mediates epithelial-mesenchymal transition to promote gastric cancer progression by transactivating APOC1 expression
Liangliang An, Yongqiang Liu
Experimental Cell Research (2022) Vol. 422, Iss. 2, pp. 113452-113452
Closed Access | Times Cited: 13
Liangliang An, Yongqiang Liu
Experimental Cell Research (2022) Vol. 422, Iss. 2, pp. 113452-113452
Closed Access | Times Cited: 13
Apolipoprotein C1 promotes tumor progression in gastric cancer
Qiou Gu, Tian Zhan, Xiao Guan, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 3, pp. 287-297
Open Access | Times Cited: 6
Qiou Gu, Tian Zhan, Xiao Guan, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 3, pp. 287-297
Open Access | Times Cited: 6
APOC1 exacerbates renal fibrosis through the activation of the NF-κB signaling pathway in IgAN
Kuipeng Yu, Lin Ding, Xin An, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Kuipeng Yu, Lin Ding, Xin An, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Exploring novel protein-based biomarkers for advancing breast cancer diagnosis: A review
Christina Jane Vellan, Tania Islam, Sumadee De Silva, et al.
Clinical Biochemistry (2024) Vol. 129, pp. 110776-110776
Closed Access | Times Cited: 1
Christina Jane Vellan, Tania Islam, Sumadee De Silva, et al.
Clinical Biochemistry (2024) Vol. 129, pp. 110776-110776
Closed Access | Times Cited: 1
NORAD-Regulated Signaling Pathways in Breast Cancer Progression
Ana Maria Capela, Carlota Tavares-Marcos, Hugo F. Estima-Arede, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 636-636
Open Access | Times Cited: 1
Ana Maria Capela, Carlota Tavares-Marcos, Hugo F. Estima-Arede, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 636-636
Open Access | Times Cited: 1
Accurate Identification of Spatial Domain by Incorporating Global Spatial Proximity and Local Expression Proximity
Yuanyuan Yu, Yao He, Zhi Xie
Biomolecules (2024) Vol. 14, Iss. 6, pp. 674-674
Open Access | Times Cited: 1
Yuanyuan Yu, Yao He, Zhi Xie
Biomolecules (2024) Vol. 14, Iss. 6, pp. 674-674
Open Access | Times Cited: 1
Mechanistic Insights into Cisplatin Response in Breast Tumors: Molecular Determinants and Drug/Nanotechnology-Based Therapeutic Opportunities
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, et al.
Mutation Research/Reviews in Mutation Research (2024) Vol. 794, pp. 108513-108513
Closed Access | Times Cited: 1
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, et al.
Mutation Research/Reviews in Mutation Research (2024) Vol. 794, pp. 108513-108513
Closed Access | Times Cited: 1
Fei Zhou, Leiming Wang, Han Ge, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 12, pp. 2857-2866
Open Access | Times Cited: 3
Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review
Xianguang Deng, Juan Wang, Chenyi Lu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Xianguang Deng, Juan Wang, Chenyi Lu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
SECE: accurate identification of spatial domain by incorporating global spatial proximity and local expression proximity
Yuanyuan Yu, Yao He, Zhi Xie
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Yuanyuan Yu, Yao He, Zhi Xie
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
